Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
140.89
-1.28 (-0.90%)
At close: Apr 18, 2024, 4:00 PM
141.50
+0.61 (0.43%)
After-hours: Apr 18, 2024, 4:54 PM EDT

Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $7.98 billion. The enterprise value is $8.30 billion.

Market Cap 7.98B
Enterprise Value 8.30B

Important Dates

The next estimated earnings date is Monday, April 29, 2024, after market close.

Earnings Date Apr 29, 2024
Ex-Dividend Date n/a

Share Statistics

ASND has 56.61 million shares outstanding.

Shares Outstanding 56.61M
Owned by Insiders (%) 0.76%
Owned by Institutions (%) 107.81%
Float 56.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 27.13
Forward PS 18.22
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 28.01
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.56

Current Ratio 3.56
Quick Ratio 2.31
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9.76

Financial Efficiency

Return on equity (ROE) is -14,914.70% and return on invested capital (ROIC) is -91.37%.

Return on Equity (ROE) -14,914.70%
Return on Assets (ROA) -55.20%
Return on Capital (ROIC) -91.37%
Revenue Per Employee $337,148
Profits Per Employee -$608,579
Employee Count 879
Asset Turnover 0.31
Inventory Turnover 0.26

Taxes

In the past 12 months, ASND has paid $7.78 million in taxes.

Income Tax 7.78M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +75.47% in the last 52 weeks. The beta is 0.51, so ASND's price volatility has been lower than the market average.

Beta (1Y) 0.51
52-Week Price Change +75.47%
50-Day Moving Average 148.66
200-Day Moving Average 114.31
Relative Strength Index (RSI) 42.21
Average Volume (30 Days) 362,175

Short Selling Information

Short Interest 3.35M
Short Previous Month 2.94M
Short % of Shares Out 8.52%
Short % of Float n/a
Short Ratio (days to cover) 10.88

Income Statement

In the last 12 months, ASND had revenue of $296.35 million and -$534.94 million in losses. Loss per share was -$9.11.

Revenue 296.35M
Gross Profit 236.85M
Operating Income -485.32M
Pretax Income -505.14M
Net Income -534.94M
EBITDA -438.04M
EBIT -458.19M
Loss Per Share -$9.11
Full Income Statement

Balance Sheet

The company has $425.55 million in cash and $686.38 million in debt, giving a net cash position of -$260.83 million or -$4.61 per share.

Cash & Cash Equivalents 425.55M
Total Debt 686.38M
Net Cash -260.83M
Net Cash Per Share -$4.61
Equity / Book Value -155.22M
Book Value Per Share -2.74
Working Capital 538.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$497.91 million and capital expenditures -$2.55 million, giving a free cash flow of -$500.46 million.

Operating Cash Flow -497.91M
Capital Expenditures -2.55M
Free Cash Flow -500.46M
FCF Per Share -$8.89
Full Cash Flow Statement

Margins

Gross margin is 79.92%, with operating and profit margins of -163.76% and -180.51%.

Gross Margin 79.92%
Operating Margin -163.76%
Pretax Margin -170.45%
Profit Margin -180.51%
EBITDA Margin -147.81%
EBIT Margin -154.61%
FCF Margin -168.87%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.38%
Shareholder Yield -0.38%
Earnings Yield -6.65%
FCF Yield -6.23%
Dividend Details

Analyst Forecast

The average price target for ASND is $170.25, which is 20.84% higher than the current price. The consensus rating is "Buy".

Price Target $170.25
Price Target Difference 20.84%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 54.43%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASND has an Altman Z-Score of 3.75 and a Piotroski F-Score of 3.

Altman Z-Score 3.75
Piotroski F-Score 3